Management of eyelids’ primary malignancies
ABSTRACTPurpose: We report our experience in surgical management of primary malignant tumors of the eyelids. We have specified the various surgical techniques used, as well as functional and anatomical results.Patients and methods: A review of patients admitted for malignant tumor of the eyelids in...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2023-12-01
|
| Series: | Libyan Journal of Medicine |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/19932820.2023.2258668 |
| _version_ | 1827632258920480768 |
|---|---|
| author | Hsouna Zgolli Racem Choura Hamad K H Elzarrug Chiraz Abdelhedi Amel Chebbi |
| author_facet | Hsouna Zgolli Racem Choura Hamad K H Elzarrug Chiraz Abdelhedi Amel Chebbi |
| author_sort | Hsouna Zgolli |
| collection | DOAJ |
| description | ABSTRACTPurpose: We report our experience in surgical management of primary malignant tumors of the eyelids. We have specified the various surgical techniques used, as well as functional and anatomical results.Patients and methods: A review of patients admitted for malignant tumor of the eyelids in the oculoplastic department of the Hedi Raies Institute of Ophthalmology from January 2012 to December 2021.Results: One hundred and twenty-three patients with malignant eyelid tumors were hospitalized. Surgical treatment involved 114 tumor lesions, which represents 95% of the cases. One hundred and eleven lesions (97.4%) had been operated by simple tumor resection. Safety margins were, respectively, 4 mm in 63.2% and from 5 to 6 mm in 34.2%. Extemporaneous histological examination was performed in three cases (2.6%). Reconstruction involved the anterior lamella (AL) in 92 cases (80.7%), the posterior lamella (PL) in 66 cases (57.9%), the medial canthus in 18 cases (15, 8%), and lateral canthus in 4 cases (3.5%). The excision was oncological in 85 cases (74.6%) and incomplete in 19 cases (16.7%). Tumor recurrence occurred in seven cases (6.1%), after an average delay of 36 months.Conclusion: The anatomical and functional features of the eyelids require a good reconstruction of the transfixion eyelid defect. Many reconstruction methods are available, allowing extensive and complex palpebral repairs. Oncologic prognosis is conditioned by the surgical quality. |
| first_indexed | 2024-03-09T14:34:29Z |
| format | Article |
| id | doaj.art-4184bdc2abaa410a9905cdd8051fee3c |
| institution | Directory Open Access Journal |
| issn | 1993-2820 1819-6357 |
| language | English |
| last_indexed | 2024-03-09T14:34:29Z |
| publishDate | 2023-12-01 |
| publisher | Taylor & Francis Group |
| record_format | Article |
| series | Libyan Journal of Medicine |
| spelling | doaj.art-4184bdc2abaa410a9905cdd8051fee3c2023-11-27T14:59:05ZengTaylor & Francis GroupLibyan Journal of Medicine1993-28201819-63572023-12-0118110.1080/19932820.2023.2258668Management of eyelids’ primary malignanciesHsouna Zgolli0Racem Choura1Hamad K H Elzarrug2Chiraz Abdelhedi3Amel Chebbi4Department A, Hedi Rais Institute of Ophthalmology, Faculty of Medicine, Tunis El Manar University, Tunis, TunisiaDepartment B, Hedi Rais Institute of Ophthalmology, Faculty of Medicine, Tunis El Manar University, Tunis, TunisiaDepartment of Ophthalmology, University of Benghazi, Benghazi, LibyaDepartment B, Hedi Rais Institute of Ophthalmology, Faculty of Medicine, Tunis El Manar University, Tunis, TunisiaDepartment C, Hedi Rais Institute of Ophthalmology, Faculty of Medicine, Tunis El Manar University, Tunis, TunisiaABSTRACTPurpose: We report our experience in surgical management of primary malignant tumors of the eyelids. We have specified the various surgical techniques used, as well as functional and anatomical results.Patients and methods: A review of patients admitted for malignant tumor of the eyelids in the oculoplastic department of the Hedi Raies Institute of Ophthalmology from January 2012 to December 2021.Results: One hundred and twenty-three patients with malignant eyelid tumors were hospitalized. Surgical treatment involved 114 tumor lesions, which represents 95% of the cases. One hundred and eleven lesions (97.4%) had been operated by simple tumor resection. Safety margins were, respectively, 4 mm in 63.2% and from 5 to 6 mm in 34.2%. Extemporaneous histological examination was performed in three cases (2.6%). Reconstruction involved the anterior lamella (AL) in 92 cases (80.7%), the posterior lamella (PL) in 66 cases (57.9%), the medial canthus in 18 cases (15, 8%), and lateral canthus in 4 cases (3.5%). The excision was oncological in 85 cases (74.6%) and incomplete in 19 cases (16.7%). Tumor recurrence occurred in seven cases (6.1%), after an average delay of 36 months.Conclusion: The anatomical and functional features of the eyelids require a good reconstruction of the transfixion eyelid defect. Many reconstruction methods are available, allowing extensive and complex palpebral repairs. Oncologic prognosis is conditioned by the surgical quality.https://www.tandfonline.com/doi/10.1080/19932820.2023.2258668malignant tumorseyelid surgeryeyelid reconstructionoculoplasticsbasal cell carcinomatumeurs malignes |
| spellingShingle | Hsouna Zgolli Racem Choura Hamad K H Elzarrug Chiraz Abdelhedi Amel Chebbi Management of eyelids’ primary malignancies Libyan Journal of Medicine malignant tumors eyelid surgery eyelid reconstruction oculoplastics basal cell carcinoma tumeurs malignes |
| title | Management of eyelids’ primary malignancies |
| title_full | Management of eyelids’ primary malignancies |
| title_fullStr | Management of eyelids’ primary malignancies |
| title_full_unstemmed | Management of eyelids’ primary malignancies |
| title_short | Management of eyelids’ primary malignancies |
| title_sort | management of eyelids primary malignancies |
| topic | malignant tumors eyelid surgery eyelid reconstruction oculoplastics basal cell carcinoma tumeurs malignes |
| url | https://www.tandfonline.com/doi/10.1080/19932820.2023.2258668 |
| work_keys_str_mv | AT hsounazgolli managementofeyelidsprimarymalignancies AT racemchoura managementofeyelidsprimarymalignancies AT hamadkhelzarrug managementofeyelidsprimarymalignancies AT chirazabdelhedi managementofeyelidsprimarymalignancies AT amelchebbi managementofeyelidsprimarymalignancies |